Taysha Gene Therapies Inc (TSHA)

05:23 AM

Why Taysha Gene Therapies Inc. stock is rated strong buyOil Prices & Community Verified Trade Signals - newser.com

05:23 AM

04:56 AM

Why Taysha Gene Therapies Inc. stock is favored by top institutionsPortfolio Growth Summary & Real-Time Sentiment Analysis - newser.com

04:56 AM

01:49 AM

How institutional ownership impacts Taysha Gene Therapies Inc. stock2025 Biggest Moves & Weekly Watchlist for Hot Stocks - newser.com

01:49 AM

Oct 22, 2025

Taysha regains full rights to TSHA-102 gene therapy for Rett - Rett Syndrome News

Oct 22, 2025

Oct 21, 2025

Chart overlay techniques for tracking Taysha Gene Therapies Inc.Earnings Performance Report & AI Driven Stock Movement Reports - newser.com

Oct 21, 2025

Oct 21, 2025

Candlestick signals on Taysha Gene Therapies Inc. stock todayCPI Data & Advanced Technical Analysis Signals - newser.com

Oct 21, 2025

Oct 21, 2025

Tick level data insight on Taysha Gene Therapies Inc. volatilityQuarterly Portfolio Review & Long-Term Safe Investment Plans - newser.com

Oct 21, 2025

Oct 21, 2025

Raymond James Initiates Coverage on TSHA with Strong Buy Rating - GuruFocus

Oct 21, 2025

Oct 21, 2025

Taysha soars on FDA breakthrough therapy status for lead asset - MSN

Oct 21, 2025

Oct 21, 2025

Published on: 2025-10-21 00:17:01 - newser.com

Oct 21, 2025

Oct 20, 2025

Why Taysha Gene Therapies Inc. is moving today2025 Macro Impact & Free Accurate Trade Setup Notifications - newser.com

Oct 20, 2025

Oct 20, 2025

Will Taysha Gene Therapies Inc. stock continue dividend increasesEarnings Summary Report & Free AI Powered Buy and Sell Recommendations - newser.com

Oct 20, 2025

Oct 20, 2025

Olema Pharmaceuticals, Exelixis, Genmab And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga

Oct 20, 2025

Oct 20, 2025

Using R and stats models for Taysha Gene Therapies Inc. forecastingJuly 2025 Levels & Risk Managed Investment Signals - newser.com

Oct 20, 2025

Oct 19, 2025

What analysts say about Taysha Gene Therapies Inc stockStock Correlation Metrics & Zero-Cost Stock Research by Professionals - earlytimes.in

Oct 19, 2025

Oct 19, 2025

Taysha Gene Therapies Eyes Volatility Amid Key Developments - StocksToTrade

Oct 19, 2025

Oct 19, 2025

Taysha Gene Therapies Faces Challenging Market Following Recent Developments - timothysykes.com

Oct 19, 2025

Oct 18, 2025

Retail Trends: Can Taysha Gene Therapies Inc. stock double in next 5 yearsJuly 2025 WrapUp & Weekly Stock Breakout Alerts - nchmf.gov.vn

Oct 18, 2025

Oct 18, 2025

Will Taysha Gene Therapies Inc. stock maintain growth story2025 Market Sentiment & Reliable Intraday Trade Alerts - newser.com

Oct 18, 2025

Oct 18, 2025

Taysha Gene Therapies Faces Financial Pressure: Concerns Amid Heavy Losses​ - StocksToTrade

Oct 18, 2025

Oct 18, 2025

Taysha Gene Therapies Faces New Challenges Amid Market Volatility - timothysykes.com

Oct 18, 2025

Oct 18, 2025

Aug Summary: Will Taysha Gene Therapies Inc. stock maintain momentum in 2025 - nchmf.gov.vn

Oct 18, 2025

Oct 18, 2025

Weekly Earnings: Why Taysha Gene Therapies Inc. stock is seen as undervalued2025 Retail Activity & Low Drawdown Trading Strategies - nchmf.gov.vn

Oct 18, 2025

Oct 18, 2025

What catalysts could drive Taysha Gene Therapies Inc. stock higherJuly 2025 Momentum & Weekly Watchlist for Consistent Profits - nchmf.gov.vn

Oct 18, 2025

Oct 18, 2025

Taysha Gene Therapies Inc Stock Analysis and ForecastInstitutional Holding Changes & Affordable Portfolio Growth - earlytimes.in

Oct 18, 2025

Oct 18, 2025

Can Taysha Gene Therapies Inc. stock hit record highs againJuly 2025 Final Week & Growth Focused Stock Pick Reports - nchmf.gov.vn

Oct 18, 2025

Oct 17, 2025

How Regaining Full Rights to Rett Syndrome Gene Therapy Has Changed Taysha (TSHA)’s Investment Story - Yahoo Finance

Oct 17, 2025

Oct 17, 2025

Sell Signal: Why Taysha Gene Therapies Inc. stock is seen as undervalued2025 Trade Ideas & Free Expert Verified Stock Movement Alerts - nchmf.gov.vn

Oct 17, 2025

Oct 17, 2025

Taysha regains full rights to Rett syndrome gene therapy program By Investing.com - Investing.com Australia

Oct 17, 2025

Oct 17, 2025

Why Is Taysha Gene Therapies Stock Falling Friday? - Sahm

Oct 17, 2025

Oct 17, 2025

Taysha Gene Therapies regains full rights to TSHA-102 - MSN

Oct 17, 2025

Oct 17, 2025

Earnings visualization tools for Taysha Gene Therapies Inc.Insider Buying & AI Enhanced Trade Execution Alerts - newser.com

Oct 17, 2025

Oct 17, 2025

Bring it back home: Taysha regains gene therapy as option expires - BioWorld MedTech

Oct 17, 2025

Oct 17, 2025

I-Mab morphs into ‘hub-and-spoke’ biotech; Astellas passes on Taysha gene therapy - BioPharma Dive

Oct 17, 2025

Oct 17, 2025

Taysha Gene Therapies regains full rights to TSHA-102 (TSHA:NASDAQ) - Seeking Alpha

Oct 17, 2025

Oct 17, 2025

Taysha Gene Therapies (TSHA) Rating and Price Target Reaffirmed by Chardan Capital | TSHA Stock News - GuruFocus

Oct 17, 2025

Oct 17, 2025

Sandhoff Disease Treatment Market Size Projects USD 456.42 Million by 2034 - GlobeNewswire Inc.

Oct 17, 2025

Oct 17, 2025

Cantor Fitzgerald reiterates Overweight rating on Taysha Gene Therapies stock - Investing.com Canada

Oct 17, 2025

Oct 17, 2025

Needham Reiterates Taysha Gene Therapies (TSHA) with "Buy" Ratin - GuruFocus

Oct 17, 2025

Oct 17, 2025

Taysha Gene Therapies, Inc. (TSHA) Stock Analysis: 87% Potential Upside Ignites Investor Interest - DirectorsTalk Interviews

Oct 17, 2025

Oct 16, 2025

Taysha Gene Therapies price target raised to $9 from $8 at BofA - MSN

Oct 16, 2025

Oct 16, 2025

Neurogene looks ‘deeply undervalued’ after Taysha news, says H.C. Wainwright - MSN

Oct 16, 2025

Oct 16, 2025

Taysha (TSHA) Reclaims Full Rights to Key Rett Syndrome Program - GuruFocus

Oct 16, 2025

Oct 16, 2025

Taysha Gene Therapies Regains Full Rights to TSHA-102 Program - TradingView

Oct 16, 2025

Oct 16, 2025

Taysha Gene Therapies Regains Full Rights to Lead TSHA-102 - GlobeNewswire

Oct 16, 2025

Oct 16, 2025

Taysha Regains Full Rights to TSHA-102; 100% Part A Response | TSHA Stock News - Stock Titan

Oct 16, 2025